Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells
- 6 May 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 211 (1) , 69-78
- https://doi.org/10.1016/j.canlet.2004.01.038
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Up-regulation of PDCD4 in senescent human diploid fibroblastsBiochemical and Biophysical Research Communications, 2002
- Loss of p73 Induction in a Cisplatin-Resistant Bladder Cancer Cell LineMolecular Urology, 2001
- Evaluation of the Reliability of Chromosomal Imbalances Detected by Combined Use of Universal DNA Amplification and Comparative Genomic HybridizationJapanese Journal of Cancer Research, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The Hallmarks of CancerCell, 2000
- Cisplatin−DNA Adducts Inhibit Ribosomal RNA Synthesis by Hijacking the Transcription Factor Human Upstream Binding FactorBiochemistry, 1998
- Laser scanning cytometry allows detection of cell death with morphological features of apoptosis in cells stained with PICytometry, 1997
- Constitutively EnhancednblExpression Is Associated with the Induction of Internucleosomal DNA Cleavage by Actinomycin DBiochemical and Biophysical Research Communications, 1996
- Extraribosomal functions of ribosomal proteinsTrends in Biochemical Sciences, 1996